Products & Services · Finite-lived intangible assets, net

Brands — Finite-lived intangible assets, net

Viatris Brands — Finite-lived intangible assets, net decreased by 10.7% to $13.11B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.7%, from $14.69B to $13.11B.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2019
Last reportedQ4 2025

How to read this metric

A steady decrease is expected due to amortization, while a sharp decline may signal asset impairment; an increase typically follows new acquisitions of product portfolios.

Detailed definition

This metric represents the net book value of identifiable intangible assets associated with branded products that have a...

Peer comparison

Comparable to 'Net Intangible Assets' or 'Product Rights' reported by other pharmaceutical firms, often analyzed relative to the remaining useful life of the portfolio.

Metric ID: vtrs_segment_brands_finite_lived_intangible_assets_net

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$21.15B$18.58B$16.75B$14.69B$13.11B
QoQ Change-12.1%-9.9%-12.3%-10.7%
YoY Change-12.1%-9.9%-12.3%-10.7%
Range$13.11B$21.15B
CAGR-38.0%
Avg YoY Growth-11.3%
Median YoY Growth-11.4%
Current Streak4+ quarters decline

Frequently Asked Questions

What is Viatris's brands — finite-lived intangible assets, net?
Viatris (VTRS) reported brands — finite-lived intangible assets, net of $13.11B in Q4 2025.
How has Viatris's brands — finite-lived intangible assets, net changed year-over-year?
Viatris's brands — finite-lived intangible assets, net decreased by 10.7% year-over-year, from $14.69B to $13.11B.
What does brands — finite-lived intangible assets, net mean?
The remaining accounting value of branded product rights and patents that will expire over time.